Target
Dual specificity protein kinase TTK
Ligand
BDBM50569980
Substrate
n/a
Meas. Tech.
ChEMBL_2110865 (CHEMBL4819715)
Kd
0.560000±n/a nM
Citation
 Huang, MHuang, YGuo, JYu, LChang, YWang, XLuo, JHuang, YTu, ZLu, XXu, YZhang, ZZhang, ZDing, K Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors. Eur J Med Chem 211:0 (2021) [PubMed]  Article 
Target
Name:
Dual specificity protein kinase TTK
Synonyms:
Dual specificity protein kinase (TTK) | Dual specificity protein kinase TTK (MPS1) | MPS1 | MPS1L1 | Monopolar Spindle 1 (MPS1) | Monopolar Spindle 1 (Mps-1) | Monopolar Spindle 1 Kinase (MPS1) | Phosphotyrosine picked threonine-protein kinase (MPS1) | TTK | TTK_HUMAN
Type:
Protein
Mol. Mass.:
97086.79
Organism:
Homo sapiens (Human)
Description:
P33981
Residue:
857
Sequence:
MESEDLSGRELTIDSIMNKVRDIKNKFKNEDLTDELSLNKISADTTDNSGTVNQIMMMANNPEDWLSLLLKLEKNSVPLSDALLNKLIGRYSQAIEALPPDKYGQNESFARIQVRFAELKAIQEPDDARDYFQMARANCKKFAFVHISFAQFELSQGNVKKSKQLLQKAVERGAVPLEMLEIALRNLNLQKKQLLSEEEKKNLSASTVLTAQESFSGSLGHLQNRNNSCDSRGQTTKARFLYGENMPPQDAEIGYRNSLRQTNKTKQSCPFGRVPVNLLNSPDCDVKTDDSVVPCFMKRQTSRSECRDLVVPGSKPSGNDSCELRNLKSVQNSHFKEPLVSDEKSSELIITDSITLKNKTESSLLAKLEETKEYQEPEVPESNQKQWQSKRKSECINQNPAASSNHWQIPELARKVNTEQKHTTFEQPVFSVSKQSPPISTSKWFDPKSICKTPSSNTLDDYMSCFRTPVVKNDFPPACQLSTPYGQPACFQQQQHQILATPLQNLQVLASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRGKK
  
Inhibitor
Name:
BDBM50569980
Synonyms:
CHEMBL4873395
Type:
Small organic molecule
Emp. Form.:
C37H49N7O3
Mol. Mass.:
639.8301
SMILES:
COc1cc(ccc1Nc1ncc2c(C)cc(=O)n([C@@H]3CC[C@@H](CC3)NC(=O)C34CC5CC(CC(C5)C3)C4)c2n1)N1CCN(C)CC1 |r,wU:19.19,22.26,TLB:26:28:31:35.33.34,THB:33:32:29:35.34.36,33:34:31.32.37:29,36:34:31:37.28.29,36:28:31:35.33.34,(12.65,-13.19,;13.97,-12.39,;13.95,-10.85,;12.6,-10.1,;12.59,-8.56,;13.9,-7.77,;15.25,-8.52,;15.27,-10.06,;16.61,-10.81,;17.93,-10.02,;17.91,-8.48,;19.22,-7.69,;20.57,-8.45,;21.9,-7.65,;21.87,-6.11,;23.25,-8.41,;23.27,-9.95,;24.61,-10.7,;21.94,-10.74,;21.97,-12.28,;20.64,-13.07,;20.66,-14.62,;22.01,-15.37,;23.33,-14.58,;23.31,-13.03,;22.03,-16.91,;23.38,-17.66,;24.7,-16.87,;23.4,-19.2,;22.12,-19.66,;22.12,-21.06,;20.99,-22.28,;22.42,-21.88,;23.75,-22.42,;24.71,-21.21,;23.39,-21.54,;24.73,-19.75,;22.41,-20.37,;20.6,-9.99,;19.27,-10.78,;11.23,-7.8,;9.91,-8.59,;8.56,-7.85,;8.54,-6.3,;7.19,-5.55,;9.86,-5.51,;11.22,-6.27,)|
Structure:
Search PDB for entries with ligand similarity: